GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients

Clinical trial NCT02575404 · COMPLETED

Trial details

NCT number: NCT02575404
Sponsor: Providence Health & Services
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Non-Small Cell Lung Cancer Squamous Cell Carcinoma of the Head and Neck

Start date: 2016-05-16
Primary completion: 2021-01-12
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.